Game Plan Financial Advisors, LLC Bio Xcel Therapeutics, Inc. Transaction History

Game Plan Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$11.19 - $17.89 $4,476 - $7,156	400 Added 3.68%	11,280 $133,000
Q2 2022 Aug 04, 2022	BUY	$9.03 - $21.55 $98,246 - $234,464	10,880 New	10,880 $142,000
Q3 2020 Nov 09, 2020	SELL	$37.44 - $64.63 $175,406 - $302,791	-4,685 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$17.62 - $58.71 $82,549 - $275,056	4,685 New	4,685 $248,000
Q1 2020 May 07, 2020	SELL	$12.26 - $41.14 $153,250 - $514,250	-12,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$4.05 - $14.61 $50,625 - $182,625	12,500 New	12,500 $183,000

3.12M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.25M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.